Search Results 1341-1350 of 20447 for hepatitis

  1. Publications - Dora Syin, M.D. - Mayo Clinic

    Human immunodeficiency virus and hepatitis testing and prevalence among surgical patients in an urban university hospital American Journal of Surgery. 2007 ...

  2. Medical Research & Education - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Joel Streed. October 1, 2021. 9-30-2021 COVID-19 Media Only News Briefing: Treatments for COVID.

  3. Bictegravir, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    This medicine may cause a hepatitis B infection to worsen if you stop using it. Your doctor may check for the presence of hepatitis B before and during ...

  4. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

    Patients with evidence of active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Patients with positive HBsAg and/or detectable HBV DNA are ...

  5. Food and medicine after the flood - Mayo Clinic News Network

    They may be contaminated with toxins or germs that can cause illnesses, such as hepatitis or gastroenteritis. Do not eat any food that may have come into ...

  6. Insulin glargine-yfgn, recombinant (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Sharing needles or pens can result in transmission of hepatitis viruses, HIV, or other bloodborne illnesses. Your doctor will want to check your progress at ...

  7. Medical Research & Education - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Joel Streed. October 1, 2021. 9-30-2021 COVID-19 Media Only News Briefing: Treatments for COVID.

  8. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    ... Hepatitis B (HBsAg reactive), or Hepatitis C (HCV RNA (qualitative) is detected); patients with negative Hepatitis C antibody testing may not need RNA testing.

  9. Clinical Trials - AUTO1 in Relapsed or Refractory B-ALL

    Active or latent Hepatitis B virus or active Hepatitis C virus. Human Immunodeficiency Virus (HIV), human T-cell lymphotropic virus (HTLV)-1, HTLV-2, or ...

  10. A Study To Evaluate The Safety Of Bone Marrow-Derived Stem Cells For Interstitial Lung Disease In Patients With Connective Tissue Disorders - Mayo Clinic

    Hepatitis B or C. Clinically significant abnormal CBC, creatinine or AST/ALT at screening per investigators clinical discretion. Pregnant or breast feeding ...